文献速递精神分裂症与精神病性障碍心境障碍

精神分裂症抑郁的药物治疗:系统综述与荟萃分析

Treatment of depression in schizophrenia: systematic review and meta-analysis.
PubMed 文献 · Br J Psychiatry · 2017-09-07

该系统综述与荟萃分析纳入26项中低质量试验,评估抗抑郁药治疗精神分裂症伴抑郁发作的效果。荟萃分析显示抗抑郁治疗的风险差异显著,需治疗人数为5(95%CI 4-9);但敏感性分析后,所有抗抑郁药及各类别药物在终点抑郁评分的标准化均数差均无统计学显著改善。结论认为抗抑郁药可能有效,但证据混杂,需更多高质量研究。

要点

  • 抗抑郁药治疗精神分裂症抑郁的风险差异显著,NNT=5(95%CI 4-9)。
  • 使用专为精神分裂症抑郁设计的评估工具时效应量更大。
  • 敏感性分析后,终点抑郁评分的标准化均数差无统计学显著改善。

核心结论

  • 抗抑郁药可能对精神分裂症抑郁有效,但证据混杂,结论受少数低或中等质量研究限制。

研究设计与样本

  • 系统综述与荟萃分析,检索多个数据库,纳入年龄>18岁精神分裂症或相关精神病性障碍伴抑郁发作的参与者。
  • 共纳入26项中等至低质量试验,使用Cochrane风险偏倚工具进行质量评估。
  • 对全部抗抑郁药、抗抑郁药类别及个体抗抑郁药(研究足够时)进行风险差异和标准化均数差的荟萃分析。

主要发现

  • 荟萃分析发现抗抑郁治疗的风险差异显著,需治疗人数为5(95%CI 4-9)。
  • 使用专为评估精神分裂症抑郁设计的工具的研究显示更大的效应量。
  • 敏感性分析后,所有抗抑郁药在终点的标准化均数差未显示抑郁评分有统计学显著改善。
  • 任何个体抗抑郁药类别在终点抑郁评分上均未显示统计学显著改善。

关键数值与推荐

  • 需治疗人数为5(95%CI 4-9),基于风险差异的荟萃分析。
  • 敏感性分析后标准化均数差无统计学显著改善,涉及全部抗抑郁药及各类别。

临床怎么用

  • 抗抑郁药可考虑用于精神分裂症伴抑郁发作,但需结合证据混杂性谨慎决策。
  • 使用专为精神分裂症抑郁设计的评估工具可能更敏感地反映疗效。

局限性

  • 纳入研究多为中低质量,数量少,结论受限。
  • 需要进一步足够把握度的高质量研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BackgroundDepression in schizophrenia predicts poor outcomes, including suicide, yet the effectiveness of antidepressants for its treatment remains uncertain.AimsTo synthesise the evidence of the effectiveness of antidepressants for the treatment of depression in schizophrenia.MethodMultiple databases were searched and inclusion criteria included participants aged over 18 years with schizophrenia or related psychosis with a depressive episode. Papers were quality assessed used the Cochrane risk bias tool. Meta-analyses were performed for risk difference and standardised mean difference of all antidepressants, antidepressant class and individual antidepressant where sufficient studies allowed.ResultsA total of 26 moderate- to low-quality trials met inclusion criteria. In meta-analysis a significant risk difference was found in favour of antidepressant treatment, with a number needed to treat of 5 (95% CI 4-9). Studies using tools specifically designed to assess depression in schizophrenia showed a larger effect size. However, after sensitivity analysis standardised mean difference of all antidepressants did not show a statistically significant improvement in depression score at end-point, neither did any individual antidepressant class.ConclusionsAntidepressants may be effective for the treatment of depression in schizophrenia, however, the evidence is mixed and conclusions must be qualified by the small number of low- or moderate-quality studies. Further sufficiently powered, high-quality studies are needed.

来源:Br J Psychiatry,查看原文。版权归原作者所有。

引用

  1. Gregory A, Mallikarjun P, Upthegrove R, et al. Treatment of depression in schizophrenia: systematic review and meta-analysis. Br J Psychiatry. 2017. PMID: 28882827. doi:10.1192/bjp.bp.116.190520

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。